Authors
Loading...
Retrospective cohort study evaluates elevated D-dimer as a biomarker of adverse outcomes in sickle cell disease, indicating hospitalization and transfusion needs increase.
Samat et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: